Showing results (141-150 of 264) with videos related to

Sort By:
Pageof 27
The Journal of Thoracic and Cardiovascular Surgery|October 19, 2019
Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancerPeter J Kneuertz, Danjouma H Cheufou, Desmond M D'Souza, et al.
Clinical Laboratory|April 9, 2009
Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destructionStefan Hacker, Christopher Lambers, Konrad Hoetzenecker, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2019
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationMarcel Wiesweg, Thomas Herold, Martin Metzenmacher, et al.
World Journal of Transplantation|March 11, 2017
Lobar lung transplantation from deceased donors: A systematic reviewMichael Eberlein, Robert M Reed, Mayy Chahla, et al.
Journal for Immunotherapy of Cancer|April 1, 2021
Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapyJustin Ferdinandus, Martin Metzenmacher, Lukas Kessler, et al.
Iscience|October 7, 2025
LTI-03 peptide demonstrates anti-fibrotic activity in ex vivo lung slices from patients with IPFBreAnne MacKenzie, Poornima Mahavadi, Yago Amigo Pinho Jannini-Sa, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2023
TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapyLuca Hegedüs, Özlem Okumus, Fabian Mairinger, et al.
Biology|March 26, 2025
Burn-Related Glycocalyx Derangement and the Emerging Role of MMP8 in Syndecan SheddingHannes Kühtreiber, Daniel Bormann, Melanie Salek, et al.
Cancers|April 13, 2023
Lymph Node Log-Odds Ratio Accurately Defines Prognosis in Resectable Non-Small Cell Lung CancerMichal Benej, Thomas Klikovits, Tibor Krajc, et al.
Radiation Oncology (London, England)|July 16, 2022
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatmentNika Guberina, Christoph Pöttgen, Martin Schuler, et al.
Pageof 27